102 completed, 19 recruiting, 13 terminated, 7 unknown. 62 Phase 2, 50 Phase 1, 17 Not applicable, 9 Phase 3, 2 Early Phase 1.
Follow Sarcoma, Kaposi: new trials by email Literature Review of Sarcoma, Kaposi trials Research Report on Sarcoma, Kaposi
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging - Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8 | Phase 2 | Not yet recruiting | Fred Hutchinson Cancer Center | 50 | 2026-12-01 | 2026-09-17 |
| Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma Pegylated liposomal doxorubicin, Paclitaxel - Kaposi Sarcoma, HIV-1-infection | Phase 3 | Not yet recruiting | AIDS Malignancy Consortium | 130 | 2026-09-01 | 2026-01-23 |
| A Study of Propranolol to Treat Kaposi Sarcoma Propranolol - Kaposi Sarcoma | Phase 2 | Recruiting | AIDS Malignancy Consortium | 25 | 2026-08-31 | 2026-10-05 |
| Disease Evolution and Risk Factors of AIDS-related Prevalent Cancers HIV (Human Immunodeficiency Virus), AIDS | Not yet recruiting | Shenzhen Third People's Hospital | 1000 | 2026-07-01 | 2026-07-10 | |
| Precision Imaging to Evaluate Kaposi Sarcoma SkinScan3D - Kaposi Sarcoma | Not applicable | Recruiting | Washington University School of Medicine | 180 | 2026-04-10 | 2026-09-21 |
| Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV) CYT107 - Kaposi Sarcoma | Phase 2 | Recruiting | National Cancer Institute (NCI) | 55 | 2026-04-08 | 2026-08-25 |
| Propranolol for the Treatment of Kaposi Sarcoma in Adults Propranolol Hydrochloride - Kaposi Sarcoma | Phase 2 | Recruiting | Washington University School of Medicine | 25 | 2025-08-20 | 2026-04-06 |
| Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas CD146/HER2 CAR-T cells - Sarcoma, Sarcoma, Kaposi | Phase 1 / Phase 2 | Recruiting | Essen Biotech | 60 | 2025-05-29 | 2025-07-15 |
| Precision Imaging to Evaluate Kaposi Sarcoma (PRIME-KS): A Device Feasibility Trial SkinScan3D camera - Kaposi Sarcoma | Recruiting | Washington University School of Medicine | 30 | 2025-02-25 | 2026-03-25 | |
| Agnostic Therapy in Rare Solid Tumors Nivolumab - Urachal Cancer, Parathyroid Carcinoma | Phase 2 | Active not recruiting | Instituto do Cancer do Estado de São Paulo | 28 | 2024-07-16 | 2026-10-13 |
| Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease Daratumumab SC - Lymphoma, Primary Effusion | Phase 2 | Recruiting | National Cancer Institute (NCI) | 40 | 2024-07-10 | 2026-10-16 |
| Natural History Study of Kaposi Sarcoma Kaposi Sarcoma, HIV | Recruiting | National Cancer Institute (NCI) | 150 | 2024-05-15 | 2026-10-16 | |
| AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW) ARROW strategies, One-time education - Cervical Cancer, Kaposi Sarcoma | Not applicable | Recruiting | Implenomics | 4100 | 2024-05-01 | 2026-01-15 |
| Pembrolizumab Plus Lenvatinib in Previously Treated Classic Kaposi Sarcoma Pembrolizumab + Lenvatinib - Kaposi Sarcoma, Classic Kaposi Sarcoma | Phase 2 | Withdrawn | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 2024-02-01 | 2026-01-22 | |
| Trial of Ixazomib for Kaposi Sarcoma Ixazomib Citrate, Quality-of-Life Assessment, Questionnaire Administration - Kaposi Sarcoma, Skin | Phase 2 | Recruiting | AIDS Malignancy Consortium | 41 | 2023-11-07 | 2026-02-27 |
| Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC Non-Interventional, Non-Interventional Follow-up - HIV-Associated Malignant Neoplasm, HIV Infections | Completed | AIDS Malignancy Consortium | 460 | 2023-07-25 | 2026-08-14 | |
| Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers Biospecimen Collection - Anal Carcinoma, Hematopoietic and Lymphoid Cell Neoplasm | Recruiting | AIDS Malignancy Consortium | 200 | 2023-05-10 | 2026-06-01 | |
| A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer MQ719, Pembrolizumab - Cutaneous Squamous Cell Carcinoma, SCC - Squamous Cell Carcinoma | Phase 1 | Recruiting | Memorial Sloan Kettering Cancer Center | 56 | 2023-05-04 | 2026-08-12 |
| Kaposi Sarcoma Chemotherapy and Research (KS-CARE) standard of care chemotherapy - Kaposi Sarcoma, HIV | Active not recruiting | UNC Lineberger Comprehensive Cancer Center | 127 | 2023-04-25 | 2026-02-05 | |
| L19IL2/L19TNF in Skin Cancer Patients L19IL2/L19TNF - BCC - Basal Cell Carcinoma, SCC - Squamous Cell Carcinoma | Phase 2 | Unknown | Philogen S.p.A. | 70 | 2023-03-09 | 2023-10-06 |
Showing 20 of 154. Sign in to see all of them.
Acquired Immunodeficiency Syndrome (61) · HIV Infections (61) · Sarcoma (32) · AIDS-related Kaposi sarcoma (30) · Neoplasms (18) · Skin Neoplasms (16) · Lymphoma, Non-Hodgkin (13) · Squamous Cell Carcinoma of Head and Neck (12) · Lymphoma (11) · Osteosarcoma (11) · Carcinoma, Basal Cell (10) · Melanoma (10) · Carcinoma, Squamous Cell (9) · Anus Neoplasms (8)
DNA Virus Infections (154) · Neoplasms by Histologic Type (154) · Neoplasms, Connective and Soft Tissue (154) · Neoplasms, Vascular Tissue (154) · Herpesviridae Infections (153) · Infections (153) · Virus Diseases (153) · Neoplasms (136) · Sarcoma (122) · Immune System Diseases (96) · Urogenital Diseases (91) · Genital Diseases (90) · Blood-Borne Infections (79) · Communicable Diseases (79) · Lentivirus Infections (79)
Doxorubicin (10) · Zidovudine (9) · Bleomycin (7) · Vincristine (7) · Nivolumab (6) · Etoposide (5) · Interferon alpha-2 (5) · Liposomes (5) · Magnetic Resonance Spectroscopy (4) · Nelfinavir (4) · Paclitaxel (4) · Semaxinib (4) · Specimen Handling (4) · Valganciclovir (4) · liposomal doxorubicin (4)
National Cancer Institute (NCI) (35) · National Institute of Allergy and Infectious Diseases (NIAID) (17) · AIDS Malignancy Consortium (13) · Alpha Tau Medical LTD. (5) · Daiichi Pharmaceuticals (4) · Memorial Sloan Kettering Cancer Center (4) · Sequus Pharmaceuticals (4) · University of California, San Francisco (4) · Washington University School of Medicine (4) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (3) · Anderson Clinical Research (2) · Assistance Publique - Hôpitaux de Paris (2) · Case Comprehensive Cancer Center (2) · Eastern Cooperative Oncology Group (2) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (2)
United States (113) · Uganda (7) · Italy (6) · Brazil (4) · France (4) · Israel (4) · South Africa (4) · Australia (3) · Kenya (3) · Malawi (3) · Mexico (3) · Puerto Rico (2) · Spain (2) · Zimbabwe (2) · Argentina (1)
Robert Yarchoan, M.D. (10) · Ramya M Ramaswami, M.D. (7) · Dirk Dittmer, PhD (3) · Gill PS (3) · Susan E. Krown, MD (3) · Jamie Hayden Von Roenn, MD (2) · Krown S (2) · Lee Ratner, M.D., Ph.D. (2) · Miles S (2) · S Miles (2) · Sam M Mbulaiteye, M.D. (2) · Scot C. Remick, MD (2) · Von Roenn JH (2) · Alison L. Hannah, MBBS (1) · Amy P Sing, MD (1)
PMID 37740179, PMID 41845569, PMID 15633090, PMID 15652610, PMID 15750399, PMID 17269969, PMID 17846226, PMID 18079362, PMID 18224669, PMID 18384551, PMID 18470481, PMID 19451429, PMID 20407240, PMID 22430271, PMID 25345840, PMID 25970141, PMID 27002157, PMID 27863194, PMID 27866590, PMID 28341759, PMID 29149611, PMID 29365083, PMID 30354935, PMID 30402565, PMID 31154457, PMID 31520741, PMID 32276276, PMID 32493198, PMID 33677480, PMID 34862247, PMID 35025687, PMID 35080914, PMID 35247913, PMID 35279271, PMID 36028920, PMID 37352498, PMID 37368929, PMID 37962072, PMID 38941593, PMID 39356983, PMID 39915263, PMID 41286911, PMID 41680482, PMID 42282156, PMID 42847673
U01CA121947 (6), UM1CA121947 (6), U01CA070019 (5), P30CA008748 (2), P30CA043703 (2), U01CA292765 (2), 2016 (1), 2UM1CA121947 (1), N01CM62206 (1), P01CA015396 (1), P30CA006516 (1), P30CA015704 (1), P30CA023108 (1), P30CA082103 (1), R01HL060604 (1)